Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 9920123 Anti-PD-L1 antibodies, compositions and articles of manufacture

Patent 9920123 was granted and assigned to Genentech on March, 2018 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

All edits

Edits on 12 Mar, 2024

"update inverses"

edited on 12 Mar, 2024

Edits made to:

Infobox (+1 properties)

Infobox

Patent Citations Received

US Patent 11918649 PD-L1-binding molecules comprising Shiga toxin a subunit scaffolds

0

Edits on 7 Dec, 2023

"Add patent abstract"

edited on 7 Dec, 2023

Edits made to:

Article (+344 characters)

Article

Patent abstract

The present application relates to anti-PD-L1 antibodies, nucleic acid encoding the same, therapeutic compositions thereof, and their use enhance T-cell function to upregulate cell-mediated immune responses and for the treatment of T cell dysfunctional disorders, including infection (e.g., acute and chronic) and tumor immunity.

Edits on 18 Oct, 2023

"update inverses"

edited on 18 Oct, 2023

Edits made to:

Infobox (+1 properties)

Infobox

Patent Citations Received

US Patent 11786529 Treatment of indolent or aggressive B-cell lymphomas using a combination comprising BTK inhibitors

Edits on 1 Oct, 2023

"Add patent inventor(s)"

edited on 1 Oct, 2023

Edits made to:

Infobox (+7 properties)

Infobox

Patent Inventor Names

Bryan Irving0

Heather Maecker0

Henry Chiu0

Jeanne Cheung0

Sanjeev Mariathasan0

Sophie M. Lehar0

Yan Wu0

Edits on 19 Jul, 2023

"update inverses"

edited on 19 Jul, 2023

Edits made to:

Infobox (+1 properties)

Infobox

Patent Citations Received

US Patent 11701357 Treatment of B cell cancers using a combination comprising Btk inhibitors

0

Edits on 25 May, 2023

"Remove leading 0 from patent number"

edited on 25 May, 2023

Edits made to:

Infobox (+1/-1 properties)

‌

US Patent 09920123 Anti-PD-L1 antibodies, compositions and articles of manufacture US Patent 9920123 Anti-PD-L1 antibodies, compositions and articles of manufacture

Infobox

Patent Number

099201230

Patent Number

99201230

Edits on 26 Mar, 2023

"Entity importer update"

edited on 26 Mar, 2023

Infobox

Is a

0

Patent Applicant

0

Current Assignee

0

Patent Jurisdiction

United States Patent and Trademark Office

0

Patent Number

099201230

Date of Patent

March 20, 2018

0

Patent Application Number

153352780

Date Filed

October 26, 2016

0

Patent Primary Examiner

0

Edits on 19 Jan, 2022

"Created via: Entity Importer"

created this topic on 19 Jan, 2022

Edits made to:

Infobox (+9 properties)

‌

US Patent 09920123 Anti-PD-L1 antibodies, compositions and articles of manufacture

Infobox

Is a

Patent applicant

Current assignee

Patent jurisdiction

United States Patent and Trademark Office

Patent number

09920123

Date of patent

March 20, 2018

Patent application number

15335278

Date Filed

October 26, 2016

Patent primary examiner

Find more entities like US Patent 9920123 Anti-PD-L1 antibodies, compositions and articles of manufacture

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Golden Query Tool